Comparison of Lodhradi lepa and Yashtimadhu ghana vati in the treatment of Mukhdushika with respect to Acne vulgaris.

A comparative study of Lodhradi lepa and Yashtimadhu ghana vati in the management of Mukhdushika with special reference to Acne vulgaris. - ACLYMA

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/04/032659

Enrollment

Registered

2021-04-08

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L700- Acne vulgaris

Interventions

Intervention1: Lodhradi lepa Yashtimadhu ghana vati: Lodhradi lepa-A thin layer applied in upward direction once in a day and Yashtimadhu Ghana Vati (500 mg) BD with lukewarm water,for 3 months. Inter

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients willing to participate in the study. 2. Patients of either sex with age between 18 and 30 years. 3. Patients having the classical features of Mukhadushika. 4. Total duration of the illness should be less than one year. 5. Patient who have white heads, black heads, few or multiple red papule (2-4mm) with or without some pustules and slight inflammation of skin of the face.

Exclusion criteria

Exclusion criteria: 1. Patients not willing to participate in the study. 2. Patients of either sex below 18 years and above 30 years will be excluded from the study. 3. Total duration of the illness more than one year. 4. Patient on hormonal therapy will be excluded. 5. Inflammation of skin which involves chest, shoulder and back. 6. Patient suffering from DM, HTN, Asthma, systemic disorders, other skin disorders like Ã¢â?¬â?? Vitiligo, Psoriasis, Urticaria. 7. Alcoholics and/or drug abusers. 8. History of hypersensitivity to the trial drug or any of its ingredients. 9. Pregnant/ lactating woman. 10. Patients who have completed participation in any other clinical trial during the past 6 months. 11. Any other conditions, which the principal investigator thinks may exclude the patient.

Design outcomes

Primary

Measure	Time frame
Assessment will be done on the basis of prepared proforma for assessment of subjective parameter, this completely depends upon the symptoms and its grades.Timepoint: 45 days with 3 follow ups of 15 days each.	—

Secondary

Measure	Time frame
1. The Global Acne Grading SystemTimepoint: 45 days with 3 follow ups of 15 days each.	—

Countries

India

Contacts

Public ContactProf Rajendra Prasad

Banaras Hindu University

rajendraprasad051@gmail.com9411471910

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026